Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).
Share price
Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD
Presentation of the Interim Report Q1, 2023 - Apr 27
Annual and Sustainability Report 2022
Latest presentations
Analyst reports
Latest CEO Comments
APRIL 27, 2023
"Navigating troubled waters"
Read the latest CEO comments from Nikolaj Sørensen
News flow
Press Releases and News
Key financial figures
Group net revenue
623.7 MSEK
Last Twelve Months, Q222-Q123
Group EBITDA
-159.1 MSEK
Last Twelve Months, Q222-Q123
US Pharma segment EBIT
298.7 MSEK
Last Twelve Months, Q222-Q123
Cash position
278.9 MSEK
Q123
